Effects of FGF receptor peptide agonists on animal behavior under normal and pathological conditions

Neuroscience Research

Volumn 68, Issue 1, 2010, Pages 35-43

  Rudenko, Olga ^a,b   Tkach, Vadim ^a,b   Berezin, Vladimir ^a,b   Bock, Elisabeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Enkam Pharmaceuticals AS   (Denmark)

Author keywords

Anxiety like behavior; Exploratory activity; FGFR; Hexafins; Huntington's disease; Social memory

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; HEXAFIN1; HEXAFIN2; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; HUNTINGTON CHOREA; IN VIVO STUDY; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ROTAROD TEST; SOCIAL BEHAVIOR;

EID: 77954797974     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.05.002     Document Type: Article

References (62)

1. Abe K., Saito H. Effects of basic fibroblast growth factor on central nervous system functions. Pharmacol. Res. 2001, 43:307-312.
2. Alzheimer C., Werner S. Fibroblast growth factors and neuroprotection. Adv. Exp. Med. Biol. 2002, 513:335-351.
3. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 2002, 8:963-970.
4. Ay H., Ay I., Koroshetz W.J., Finklestein S.P. Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc. Dis. 1999, 9:131-135.
5. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
6. Berezin V., Bock E. NCAM mimetic peptides: pharmacological and therapeutic potential. J. Mol. Neurosci. 2004, 22:33-39.
7. Cambon K., Hansen S.M., Venero C., Herrero A.I., Skibo G., Berezin V., Bock E., Sandi C. A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation. J. Neurosci. 2004, 24:4197-4204.
8. Cheng Y.D., Al-Khoury L., Zivin J.A. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 2004, 1:36-45.
9. Conti L., Reitano E., Cattaneo E. Neural stem cell systems: diversities and properties after transplantation in animal models of diseases. Brain Pathol. 2006, 16:143-154.
10. Craufurd D., Thompson J.C., Snowden J.S. Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol. Behav. Neurol. 2001, 14:219-226.
11. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:248-258.
12. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol. Psychiatry 2007, 62:1341-1346.
13. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., Walsh D.M., Myers R.M., Bunney W.E., Watson S.J., Jones E.G., Akil H. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15506-15511.
14. Ford-Perriss M., Abud H., Murphy M. Fibroblast growth factors in the developing central nervous system. Clin. Exp. Pharmacol. Physiol. 2001, 28:493-503.
15. Ganat Y., Soni S., Chacon M., Schwartz M.L., Vaccarino F.M. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience 2002, 112:977-991.
16. Gomez-Pinilla F., Dao L., Choi J., Ryba E.A. Diazepam induces FGF-2 mRNA in the hippocampus and striatum. Brain Res. Bull. 2000, 53:283-289.
17. Gonzalez A.M., Berry M., Maher P.A., Logan A., Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 1995, 701:201-226.
18. Grothe C., Timmer M. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res. Rev. 2007, 54:80-91.
19. Grothe C., Meisinger C., Claus P. In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia. J. Comp. Neurol. 2001, 434:342-357.
20. Hudson L.C., Hughes C.S., Bold-Fletcher N.O., Vaden S.L. Cerebrospinal fluid collection in rats: modification of a previous technique. Lab. Anim. Sci. 1994, 44:358-361.
21. Iwata T., Hevner R.F. Fibroblast growth factor signaling in development of the cerebral cortex. Dev. Growth Differ. 2009, 51:299-323.
22. Jensen P., Pedersen E.G., Zimmer J., Widmer H.R., Meyer M. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease. Brain Res. 2008, 1218:13-20.
23. Jin K., Sun Y., Xie L., Batteur S., Mao X.O., Smelick C., Logvinova A., Greenberg D.A. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2003, 2:175-183.
24. Jin K., LaFevre-Bernt M., Sun Y., Chen S., Gafni J., Crippen D., Logvinova A., Ross C.A., Greenberg D.A., Ellerby L.M. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18189-18194.
25. Kiselyov V.V., Skladchikova G., Hinsby A.M., Jensen P.H., Kulahin N., Soroka V., Pedersen N., Tsetlin V., Poulsen F.M., Berezin V., Bock E. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 2003, 11:691-701.
26. 25-35. Neuroscience 2007, 145:209-224.
27. Klempir J., Klempirova O., Stochl J., Spackova N., Roth J. The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease. J. Neurol. 2009, 256:1629-1633.
28. Kulahin N., Li S., Hinsby A., Kiselyov V., Berezin V., Bock E. Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor. Mol. Cell. Neurosci. 2008, 37:528-536.
29. Lawrence A.D., Sahakian B.J., Rogers R.D., Hodge J.R., Robbins T.W. Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection. Neuropsychologia 1999, 37:1359-1374.
30. Lawrence A.D., Watkins L.H., Sahakian B.J., Hodges J.R., Robbins T.W. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 2000, 123:1349-1364.
31. Lever C., Burton S., O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev. Neurosci. 2006, 17:111-133.
32. Li S., Christensen C., Kohler L.B., Kiselyov V.V., Berezin V., Bock E. Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons. Dev. Neurobiol. 2009, 69:837-854.
33. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 1987, 92:180-185.
34. Lynch G., Kramar E.A., Rex C.S., Jia Y., Chappas D., Gall C.M., Simmons D.A. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci. 2007, 27:4424-4434.
35. Mallei A., Shi B., Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 2002, 61:1017-1024.
36. McBride J.L., Ramaswamy S., Gasmi M., Bartus R.T., Herzog C.D., Brandon E.P., Zhou L., Pitzer M.R., Berry-Kravis E.M., Kordower J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9345-9350.
37. Morris M. Dementia and cognitive changes in Huntington's disease. Adv. Neurol. 1995, 65:187-200.
38. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004, 3:287-302.
39. Mudo G., Bonomo A., Di Liberto V., Frinchi M., Fuxe K., Belluardo N. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J. Neural Transm. 2009, 116:995-1005.
40. Nadler J.J., Moy S.S., Dold G., Trang D., Simmons N., Perez A., Young N.B., Barbaro R.P., Piven J., Magnuson T.R., Crawley J.N. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. 2004, 3:303-314.
41. Neiiendam J.L., Kohler L.B., Christensen C., Li S., Pedersen M.V., Ditlevsen D.K., Kornum M.K., Kiselyov V.V., Berezin V., Bock E. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J. Neurochem. 2004, 91:920-935.
42. Ornitz D.M. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 2000, 22:108-112.
43. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 1986, 24:525-529.
44. Perez J.A., Clinton S.M., Turner C.A., Watson S.J., Akil H. A new role for FGF2 as an endogenous inhibitor of anxiety. J. Neurosci. 2009, 29:6379-6387.
45. Popik P., van Ree J.M. Neurohypophyseal peptides and social recognition in rats. Prog. Brain Res. 1998, 119:415-436.
46. Popov V.I., Medvedev N.I., Kraev I.V., Gabbott P.L., Davies H.A., Lynch M., Cowley T.R., Berezin V., Bock E., Stewart M.G. A cell adhesion molecule mimetic, FGL peptide, induces alterations in synapse and dendritic spine structure in the dentate gyrus of aged rats: a three-dimensional ultrastructural study. Eur. J. Neurosci. 2008, 27:301-314.
47. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463:3-33.
48. Ren J.M., Finklestein S.P. Growth factor treatment of stroke. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:121-125.
49. Reuss B., von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 2003, 313:139-157.
50. Rohrer D., Salmon D.P., Wixted J.T., Paulsen J.S. The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory. Neuropsychology 1999, 13:381-388.
51. Secher T., Novitskaia V., Berezin V., Bock E., Glenthoj B., Klementiev B. A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention. Neuroscience 2006, 141:1289-1299.
52. Snowden J.S., Craufurd D., Thompson J., Neary D. Psychomotor, executive, and memory function in preclinical Huntington's disease. J. Clin. Exp. Neuropsychol. 2002, 24:133-145.
53. Thompson J.C., Snowden J.S., Craufurd D., Neary D. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. J. Neuropsychiatry Clin. Neurosci. 2002, 14:37-43.
54. Thor D.H., Wainwright K.L., Holloway W.R. Persistence of attention to a novel conspecific: some developmental variables in laboratory rats. Dev. Psychobiol. 1982, 15:1-8.
55. Turner C.A., Akil H., Watson S.J., Evans S.J. The fibroblast growth factor system and mood disorders. Biol. Psychiatry 2006, 59:1128-1135.
56. Turner C.A., Gula E.L., Taylor L.P., Watson S.J., Akil H. Antidepressant-like effects of intracerebroventricular FGF2 in rats. Brain Res. 2008, 1224:63-68.
57. Wang Z.L., Cheng S.M., Ma M.M., Ma Y.P., Yang J.P., Xu G.L., Liu X.F. Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia. Neurosci. Lett. 2008, 446:30-35.
58. Watkins L.H., Rogers R.D., Lawrence A.D., Sahakian B.J., Rosser A.E., Robbins T.W. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia 2000, 38:1112-1125.
59. Xu C., Rosler E., Jiang J., Lebkowski J.S., Gold J.D., O'Sullivan C., Delavan-Boorsma K., Mok M., Bronstein A., Carpenter M.K. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 2005, 23:315-323.
60. Yoshimura S., Takagi Y., Harada J., Teramoto T., Thomas S.S., Waeber C., Bakowska J.C., Breakefield X.O., Moskowitz M.A. FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5874-5879.
61. Yoshimura S., Teramoto T., Whalen M.J., Irizarry M.C., Takagi Y., Qiu J., Harada J., Waeber C., Breakefield X.O., Moskowitz M.A. FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J. Clin. Invest. 2003, 112:1202-1210.
62. Zuccato C., Ciammola A., Rigamonti D., Leavitt B.R., Goffredo D., Conti L., MacDonald M.E., Friedlander R.M., Silani V., Hayden M.R., Timmusk T., Sipione S., Cattaneo E. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.